| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/04/2022 | 74.29% | Goldman Sachs | $24 → $21 | Maintains | Buy |
| 09/27/2022 | 82.59% | JMP Securities | → $22 | Initiates Coverage On | → Market Outperform |
| 12/29/2021 | 132.39% | HC Wainwright & Co. | $23 → $28 | Maintains | Buy |
| 08/31/2021 | 90.89% | HC Wainwright & Co. | $20 → $23 | Maintains | Buy |
| 08/06/2021 | 57.69% | Goldman Sachs | → $19 | Initiates Coverage On | → Buy |
| 08/05/2021 | 65.99% | HC Wainwright & Co. | $16 → $20 | Maintains | Buy |
| 02/01/2021 | 24.49% | HC Wainwright & Co. | $14 → $15 | Maintains | Buy |
| 11/06/2020 | 16.19% | HC Wainwright & Co. | $12 → $14 | Maintains | Buy |
| 08/07/2020 | -0.41% | HC Wainwright & Co. | $14 → $12 | Maintains | Buy |
| 08/03/2020 | 16.19% | HC Wainwright & Co. | $12 → $14 | Maintains | Buy |
| 03/12/2020 | -0.41% | HC Wainwright & Co. | $13 → $12 | Reiterates | → Buy |
| 10/18/2019 | 7.89% | HC Wainwright & Co. | → $13 | Initiates Coverage On | → Buy |
| 07/11/2019 | — | Cantor Fitzgerald | Upgrades | Neutral → Overweight | |
| 11/06/2018 | 107.49% | RBC Capital | $26 → $25 | Maintains | Outperform |
| 05/10/2018 | — | JP Morgan | Upgrades | Neutral → Overweight | |
| 02/14/2018 | — | JP Morgan | Downgrades | Overweight → Neutral | |
| 02/14/2018 | 107.49% | JP Morgan | $31 → $25 | Maintains | Neutral |
| 11/10/2017 | 107.49% | Cantor Fitzgerald | $24 → $25 | Maintains | Overweight |
Dynavax Technologies Questions & Answers
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by JMP Securities on September 27, 2022. The analyst firm set a price target for $22.00 expecting DVAX to rise to within 12 months (a possible 82.59% upside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for Dynavax Technologies (NASDAQ: DVAX) was provided by JMP Securities, and Dynavax Technologies initiated their market outperform rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dynavax Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dynavax Technologies was filed on September 27, 2022 so you should expect the next rating to be made available sometime around September 27, 2023.
While ratings are subjective and will change, the latest Dynavax Technologies (DVAX) rating was a initiated with a price target of $0.00 to $22.00. The current price Dynavax Technologies (DVAX) is trading at is $12.05, which is within the analyst's predicted range.